Clinical Trial

The Effects of Magnesium (Mg) Supplement and Alternate Maxillary Expansion and Constriction (Alt-RAMEC) in Patient With Transverse Maxillary Deficiency (TMD)

Study acronym: Mg + Alt-RAMEC
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 30, 2025 (before its estimated August 12, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized clinical trial evaluates the effect of combining magnesium supplementation with an orthodontic technique called Alternate Maxillary Expansion and Constriction (Alt-RAMEC) using a Micro-implant Assisted Rapid Palatal Expansion (MARPE) appliance to treat adults (18-30 years) with transverse maxillary deficiency (TMD). TMD is a condition where the upper jaw is narrower than normal, which can affect bite and facial development. The study involves two groups: one receiving the Alt-RAMEC protocol with MARPE alone, and the other receiving the same protocol alongside oral magnesium supplements. The effectiveness of these treatments will be compared by assessing changes in dental and skeletal structures through imaging techniques and evaluating muscle function. Participants will also report their pain and discomfort levels during the treatment. This research aims to understand whether magnesium supplementation can enhance the effects of Alt-RAMEC treatment, improve patient outcomes, and reduce discomfort associated with orthodontic procedures.
Trial Details
NCT Number NCT07309640
Lead Sponsor Universiti Sains Malaysia
Conditions Magnesium During Orthodontic Expansion, Orthodontic Patients Indicated for Maxillary Expansion
Enrollment 38 participants
Start Date 2026-01-01
Primary Completion 2026-08-12 (estimated)
Study Completion 2026-09-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-30